ClinicalTrials.Veeva

Menu
F

Family Care Research | Boise, ID

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

RDV
Allopurinol
Elinzanetant
LF111
Remdesivir
Drospirenone
BAY3427080

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD)...

Enrolling
Change in Bone Mineral Density
Bone Loss
Drug: LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet

The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the effi...

Enrolling
Hyperuricemia
Tophi
Drug: Allopurinol
Drug: Tigulixostat

Trial sponsors

Bayer logo
Gilead Sciences logo
I
LG Chem logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems